ABBVIE INC. (ABBV)
Clinical trial NCT05904106 updates: 1. completion date: 2028-09-01 → 2030-09-01 2. primary completion date: 2028-09-01 → 2030-09-01
Clinical trial NCT05904106 updates: 1. completion date: 2028-09-01 → 2030-09-01 2. primary completion date: 2028-09-01 → 2030-09-01
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical